It’s a notion that might be pulled from the pages of science-fiction novel – electronic devices that can be injected directly into the brain, or other body parts, and treat everything from neurodegenerative disorders to paralysis.
It sounds unlikely, until you visit Charles Lieber’s lab.
A team of international researchers, led by Lieber, the Mark Hyman, Jr. Professor of Chemistry, an international team of researchers developed a method for fabricating nano-scale electronic scaffolds that can be injected via syringe. Once connected to electronic devices, the scaffolds can be used to monitor neural activity, stimulate tissues and even promote regenerations of neurons. The study is described in a June 8 paper in Nature Nanotechnology.
Contributing to the work were Jia Liu, Tian-Ming Fu, Zengguang Cheng, Guosong Hong, Tao Zhou, Lihua Jin, Madhavi Duvvuri, Zhe Jiang, Peter Kruskal, Chong Xie, Zhigang Suo, Ying Fang
“I do feel that this has the potential to be revolutionary,” Lieber said. “This opens up a completely new frontier where we can explore the interface between electronic structures and biology. For the past thirty years, people have made incremental improvements in micro-fabrication techniques that have allowed us to make rigid probes smaller and smaller, but no one has addressed this issue – the electronics/cellular interface – at the level at which biology works.”
The idea of merging the biological with the electronic is not a new one for Lieber.
In an earlier study, scientists in Lieber’s lab demonstrated that the scaffolds could be used to create “cyborg” tissue – when cardiac or nerve cells were grown with embedded scaffolds. Researchers were then able to use the devices to record electrical signals generated by the tissues, and to measure changes in those signals as they administered cardio- or neuro-stimulating drugs.
“We were able to demonstrate that we could make this scaffold and culture cells within it, but we didn’t really have an idea how to insert that into pre-existing tissue,” Lieber said. “But if you want to study the brain or develop the tools to explore the brain-machine interface, you need to stick something into the body. When releasing the electronics scaffold completely from the fabrication substrate, we noticed that it was almost invisible and very flexible like a polymer and could literally be sucked into a glass needle or pipette. From there, we simply asked, would it be possible to deliver the mesh electronics by syringe needle injection, a process common to delivery of many species in biology and medicine – you could go to the doctor and you inject this and you’re wired up.'”
Though not the first attempts at implanting electronics into the brain – deep brain stimulation has been used to treat a variety of disorders for decades – the nano-fabricated scaffolds operate on a completely different scale.
“Existing techniques are crude relative to the way the brain is wired,” Lieber explained. “Whether it’s a silicon probe or flexible polymers…they cause inflammation in the tissue that requires periodically changing the position or the stimulation. But with our injectable electronics, it’s as if it’s not there at all. They are one million times more flexible than any state-of-the-art flexible electronics and have subcellular feature sizes. They’re what I call “neuro-philic” – they actually like to interact with neurons..”
Despite their enormous potential, the fabrication of the injectable scaffolds is surprisingly easy.
“That’s the beauty of this – it’s compatible with conventional manufacturing techniques,” Lieber said.
Read more: Injectable electronics
The Latest on: Injectable electronics
[google_news title=”” keyword=”Injectable electronics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Injectable electronics
- Automotive Electronicson May 6, 2024 at 4:59 pm
Molex has introduced MX-Dash, a family of single automotive connectors that combine power, signal and high-speed data inserts for zonal architectures. In wire-to-wire and wire-to-board form, they are ...
- Global Generic Injectable Market Poised for Remarkable Growth, Projected to Reach US$ 3,22,433.1 Million by 2033on May 1, 2024 at 9:07 pm
The global generic injectable market is set to witness unprecedented expansion, with a projected valuation of US$ 3,22,433.1 million by the year 2033. According to recent market analysis, the sector ...
- Your Guide to Injectable Alternatives to Statinson April 30, 2024 at 5:00 pm
However, in recent years, injectable alternatives such as PCSK9 Inhibitors have been introduced to help reduce cholesterol levels. High cholesterol can increase your risk of developing heart ...
- New treatment strategy could bring children with pneumonia home from hospital earlieron April 29, 2024 at 5:00 pm
Children who are recovering from severe pneumonia could safely switch from injectable to oral antibiotics earlier, allowing them to come home from hospital sooner. This is according to new results ...
- Eli Lilly acquires Nexus Pharmaceuticals Pleasant Prairie facilityon April 29, 2024 at 1:00 pm
Indiana-based pharmaceutical company Eli Lilly and Illinois-based sterile manufacturer Nexus Pharmaceuticals, LLC recently announced an agreement for Lilly to acquire a manufacturing facility from ...
- 10 Things to Know Before You Buy Refurbished Electronicson April 21, 2024 at 5:00 pm
These tips can help you get a deal and avoid being ripped off when buying refurbished laptops, TVs, phones, and other electronics. I've been writing about computers, the internet, and technology ...
- Don't Chuck That Tech: 7 Simple Ways to Recycle Electronicson April 17, 2024 at 5:00 pm
Need to dispose of an old TV, laptop, phone, or other gadget? There are tons of easy (and often free) ways to recycle your old gear and make sure it doesn't end up in a landfill. My title is ...
- Medincell, AbbVie link up in long-acting injectable development pact worth up to $1.9Bon April 17, 2024 at 7:49 am
After proving the merits of its drug delivery platform last year with the approval of Teva’s long-acting schizophrenia drug Uzedy, France’s Medincell has hooked another big-name partner.
- Medincell, AbbVie to Co-Develop Injectable Therapeuticson April 16, 2024 at 9:11 am
Medincell and AbbVie plan to co-develop and commercialize as many as six injectable therapies under a collaboration deal worth up to nearly $2 billion. Medincell can rake in as much as $1.9 ...
- Introducing Groundbreaking Injectable Steroids for Advanced Fat Losson April 15, 2024 at 2:21 pm
In the competitive landscape of bodybuilding and athletic enhancement, access to premium quality injectable steroids has been a game-changer for many. Recognized as a top-tier resource for high ...
via Bing News